Exelixis
Price & Volume
Stats
See more52W Range | $32.38-$49.62 |
Market Cap | $11.2B |
Shares Short | 26M |
Financials
See moreRevenue (12 Mos) | $2.3B |
Revenue Growth (YoY) | 5.6% |
Gross Profit (12 Mos) | $2.2B |
Diluted EPS | $2.81 |
News
See moreYahoo Finance • 2 days ago
Recurrent Head and Neck Cancer Squamous Cell Carcinoma Markets and Competition Outlook 2026-2030: Personalized Medicine Drives Revenue Growth, Reaching $4.61 Billion by 2030
Yahoo Finance • 4 days ago
RBC Capital Lowers Exelixis (EXEL) Price Target to $43
Yahoo Finance • last month
Here’s What Analysts Think About Arcus Biosciences (RCUS)
Yahoo Finance • 2 months ago
Biogen Announces Board Chair Transition
About
CEO | Dr. Michael M. Morrissey Ph.D. |
CFO | Mr. Christopher J. Senner |
Address | 1851 Harbor Bay Parkway, Alameda, CA, United States, 94502 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,077 |
